Results 341 to 350 of about 2,643,192 (369)
Some of the next articles are maybe not open access.

Combination Intravesical Therapy

Urologic Clinics of North America, 2020
After Bacillus Calmette-Guerin (BCG) failure, there is likely a 6- to 24-month window whereby salvage intravesical therapy might allow for preservation of the bladder without disease worsening. Combination intravesical, salvage therapy for nonmuscle invasive bladder cancer represents a promising avenue for treatment in patients unfit or unwilling to ...
Michael A. O’Donnell, Nathan A. Brooks
openaire   +2 more sources

Combination therapy

Respiratory Care Clinics of North America, 2001
Although not allowing one to state conclusively that a particular combination of approaches to CMV and adjuncts to CMV affect outcome, the results are encouraging. Independently, none of the modalities discussed-HFV, ECMO, NO, or PLV-have shown a statistically significant improvement in outcome except NO.
openaire   +2 more sources

Combination therapies

2012
Spinal cord injury (SCI) has multiple consequences, ranging from molecular imbalances to glial scar formation to functional impairments. It is logical to think that a combination of single treatments implemented in the right order and at the right time will be required to repair the spinal cord.
Oudega, M, Bradbury, E J, Ramer, M S
openaire   +4 more sources

The rationale for combination therapy

British Journal of Dermatology, 2001
Fungal infections of the nail are common in European populations. There are a number of clinical presentations usually resulting from an infection by one of the dermatophyte species, notably Trichophyton rubrum. A number of modern treatment strategies are available and are generally well tolerated and effective.
openaire   +3 more sources

Combined modality therapy

Current Opinion in Oncology, 1991
Encouraging results continue to emerge with the use of chemoradiotherapy. This review of the current literature demonstrates some of the advances that have been achieved in a variety of common malignancies with strategies based on well-defined rationales.
Timothy J. Kinsella, Cornelius J. McGinn
openaire   +3 more sources

Combination therapy of dyslipidemia

Current Treatment Options in Cardiovascular Medicine, 2007
Clinical trials have demonstrated the benefit of low-density lipoprotein (LDL) cholesterol reduction and, with less robust evidence, reduction of triglyceride levels and increased high-density lipoprotein (HDL) cholesterol in the prevention of atherosclerotic cardiovascular disease.
openaire   +3 more sources

Combination therapy for dyslipidemia

Current Opinion in Cardiology, 2011
Residual cardiovascular risk remains in individuals treated with statins and combination therapies may reduce this risk further.Most previous trials of combination therapies have shown a favorable effect on lipid profiles without clinical superiority over statin monotherapy.
openaire   +3 more sources

Combination Therapy with Thrombolysis

2017
Thrombolysis is the most effective treatment for acute ischemic stroke representing the basic therapeutic standard in the western world. Novel drug treatments are therefore unlikely to be developed as stand-alone approaches and every novel treatment should be considered as combination treatment together with thrombolysis.
Yuluğ, Burak, Schaebitz, Wolf-Ruediger
openaire   +3 more sources

Combination Therapy in Hypertension

Advances in Therapy, 2013
Hypertension is recognized as a major risk factor for cardiovascular and renal diseases and represents the leading cause of mortality worldwide. In spite of proven benefits of hypertension treatment, blood pressure control rates are poor, even in high-income countries with virtually full-access to therapies.
Alejandro de la Sierra, Manuel Gorostidi
openaire   +3 more sources

Antihypertensive combination therapy

Drugs of Today, 1998
The rationale behind employing combination antihypertensive therapy stems from growing evidence that there is a greater need for more aggressive control of systemic arterial pressure to levels below what we have traditionally accepted (140/90 mmHg), and that we have had historically poor control rates with existing approaches to antihypertensive ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy